Neuroendocrine Tumours of the Alimentary Tract – History and at Present
Authors:
V. Mandys
Authors place of work:
Ústav patologie 3. lékařské fakulty UK a FNKV, Praha
Published in the journal:
Čes.-slov. Patol., 45, 2009, No. 3, p. 57-63
Category:
Přehledový článek
Summary
Histological classification of the neuroendocrine tumours (”carcinoids“) of the alimentary tract, as well as the opinion on biological behaviour of these tumours, changed rapidly within the last decade. Advances in knowledge of cellular biology of the diffuse endocrine system and in clinical diagnostics and treatment of tumours lead to the creation of a new histological classification of neuroendocrine tumours. This classification, apart from essential histological picture and immunohistological characterisation of the markers of neuroendocrine differentiation, also includes definition of biological properties of tumours based on their site of origin, mitotic and proliferative activity of the tumour cells and clinicopathological correlation, including the size of the tumour and its progression. Exact classification of an individual tumour into a corresponding category is an essential condition to select adequate following diagnostic procedures and optimal therapeutic strategy.
Key words:
neuroendocrine tumours – alimentary tract – histological classification – imunohistological markers – biological behaviour
Zdroje
1. Ahlman, H., Nilsson, O., McNicol, A.M. et al.: Poorly-differentiated endocrine carcinomas of midgut and hindgut origin. Neuroendocrinology, 2008, 87: 40–6.
2. Bordi, C., DęAdda, T., Pizzi, S. et al.: The assessment of malignancy in endocrine tumours of the gastrointestinal tract. Current Diagnostic Pathology, 2002, 8: 421–9.
3. Burke, A.P., Sobin, L.H., Federspiel, B.H., Shekitka, K.M., Helwig, E.B.: Goblet cell carcinoids and related tumors of the vermiform appendix. Am J Clin Pathol, 1990, 94/1: 27–35.
4. Calender, A.: Genetics of neuroendocrine tumours. In: Handbook of Neuroendocrine tumours. Their current and future management. Caplin, M., Kvols, L. Eds., 2006, Bristol, BioStientifica.
5. Cooper, H.S.: Intestinal neoplasms. In: Diagnostic Surgical Pathology, volume 2, Third Edition, Sternberg, S.S., Antonioli, D.A., Carter, D., Mills, S.E., Oberman, H.A., Eds., 1999. Philadelphia, Baltimore, New York, Lippincott, Williams, Wilkins.
6. Eriksson, B., Klöppel, G., Krenning, E. et al. Consensus guidelines for the management of patients with digestive neuroendocrine tumors – well-differentiated jejunal-ileal tumor/carcinoma. Neuroendocrinology, 2008, 87: 8–19.
7. Fenoglio-Preiser, C. et al. Neoplastic lesions of the small intestine. In.: Gastrointestinal Pathology - an Atlas and Text. Lippincot-Raven Publishers, Philadelphia, New York, 1999, s. 481–495.
8. Ferolla, P., Faggiano, A., Mansueto, G., et al.: The biological characterization of neuroendocrine tumors: The role of neuroendocrine markers. J Endocrinol Invest, 2008, 31: 277–86.
9. Ghaferi, A.A., Chojnacki, K.A., Long, W.D. et al.: Pancreatic VIPomas: subject review and one institutional experience. J Gastrointest Surg, 2008, 12/2: 382–93.
10. Goddard, M.J., Lonsdale, R.N.: The histogenesis of appendiceal carcinoid tumours. Histopathology, 1992, 20/4: 345–9.
11. Grant, C.S.: Insulinoma. Best Pract Res Clin Gastroenterol. 2005, 19/5: 783–98.
12. Hamilton, S.R., Aaltonen, L.A.: Pathology & Genetics Tumours of the Digestive System. World Health Organization Classification of Tumours. 2000. Lyon, IARC Press.
13. de Herder, W.W., Niederle, B., Scoazec, J-Y. et al.: Well-differentiated pancreatic tumor/carcinoma: Insulinoma. Neuroendocrinology, 2006, 84: 183–8.
14. Jensen, R.T., Niederle, B., Mitry, E. et al.: Gastrinoma (duodenal and pancreatic). Neuroendocrinology, 2006, 84: 173–82.
15. Jirásek, T., Hozák, P., Mandys, V.: Different patterns of chromogranin A and Leu-7 (CD57) expression in gastrointestinal carcinoids: immunohistochemical and confocal laser scanning microscopy study. Neoplasma, 2003, 50/1: 1–7.
16. Jirásek, T., Mandys, V.: Karcinoidy gastrointestinálního traktu: význam hodnocení diferenciačních a proliferačních markerů. Čes-slov Patol, 2003, 39/2: 47–53.
17. Jirásek, T., Mandys, V.: Immunohistochemical Expression of Chromogranin A and Leu-7 in Gastrointestinal Carcinoids. In: Imunohistochemistry and in situ Hybridization of Human Carcinomas. Molecular genetics, gastrointestinal carcinoma, and ovarian carcinoma. Vol. 4, II. Gastrointestinal Carcinoma, Hayat, M.A. Ed., 2006, Amsterdam, Boston, Heidelberg, Academic Press.
18. Kanthan, R., Saxena, A., Kanthan S.C.: Goblet cell carcinoids of the appendix: immunophenotype and ultrastructural study. Arch Pathol Lab Med, 2001, 125(3): 386–90.
19. Kasprzak, A., Zabel, M., Biczysko, W.: Selected markers (chromogranin A, neuron-specific enolase, synaptophysin, protein gene product 9.5) in diagnosis and prognosis of neuroendocrine pulmonary tumours. Pol J Pathol, 2007, 58(1): 23–33.
20. Maggard, M.A., O‘Connell, J.B., Ko, C.Y.: Updated population-based review of carcinoid tumors. Ann Surg. 2004, 240/1: 117–22.
21. Mansour, J.C., Chen, H.: Pancreatic endocrine tumors. J Surg Res, 2004, 120/1: 139–61.
22. Modlin, I.M., Zikusoka, M, Kidd, M. et al.: The history and epidemiology of neuroendocrine tumours. In: Handbook of neuroendocrine tumours. Their current and future management. Caplin, M., Kvols, L. Eds., 2006, Bristol, BioStientifica.
23. Nehar, D., Lombard-Bohas, C., Olivieri, S. et al.: Interest of chromogranin A for diagnosis and follow up of endocrine tumours. Clin Endocrinol, 2004, 60: 644–52.
24. Nilsson, O., Van Cutsem, E., Delle Fave, G. et al.: Poorly differentiated carcinomas of the foregut (gastric, duodenal and pancreatic). Neuroendocrinology, 2006, 84: 212–5.
25. O‘Grady, H.L., Conlon, K.C.: Pancreatic neuroendocrine tumours. Eur J Surg Oncol, 2008, 34/3: 324–32.
26. Plöckinger, U., Rindi, G., Arnold, R. et al.: Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. Neuroendocrinology, 2004, 80: 394–424.
27. Plöckinger, U., Couvelard, A., Falconi, M. et al.: Consensus guidelines for the management of patients with digestive neuroendocrine tumours: well-differentiated tumour/carcinoma of the appendix and goblet cell carcinoma. Neuroendocrinology, 2008, 87: 20–30.
28. Ramage, J.K., Davies, A.H., Ardill, J. et al.: Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut, 2005, 54 (Suppl IV): iv1–iv16.
29. Ramage, J.K., Goretzki, P.E., Manfredi, R. et al.: Consensus guidelines for the management of patients with digestive neuroendocrine tumours: well-differentiated colon and rectum tumour/carcinoma. Neuroendocrinology, 2008, 87: 31–9.
30. Rindi, G., Klöppel, G.: Endocrine tumors of the gut and pancreas: tumor biology and classification. Neuroendocrinology, 2004, 80 (Suppl 1): 12–5.
31. Rindi, G., Klöppel, G., Alhman, H. et al.: TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch, 2006, 449/4, 395–401.
32. Rindi, G., Bordi, C.: Classification of neuroendocrine tumours. In: Handbook of neuroendocrine tumours. Their current and future management. Caplin, M., Kvols, L. Eds., 2006, Bristol, BioStientifica.
33. Ruszniewski, P., Delle Fave, G., Cadiot, G. et al.: Well-differentiated gastric tumors/carcinomas. Neuroendocrinology, 2006, 84: 158–64.
34. Soga, J.: The term „carcinoid“ is a misnomer: the evidence based on local invasion. J Exp Clin Cancer Res, 2009, 28/1: 15.
35. Solcia, E., Klöppel, G., Sobin, L.H.: Histological typing of endocrine tumours, Second Edition, World Health Organization International Histological Classification of Tumours. 2000. Berlin, Heidelberg, New York, Springer.
36. Starker, L.F., Carling, T.: Molecular genetics of gastroenteropancreatic neuroendocrine tumors. Curr Opin Oncol, 2009, 21/1: 29–33.
37. Takenaka, Y., Tsukamoto, T., Mizoshita, T. et al.: Gastric and intestinal phenotypic correlation between exocrine and endocrine components in human stomach tumors. Histol Histopathol, 2007, 22/3: 273–84.
38. Temple, W.J., Sugarbaker, E.V., Ketcham, A.S.: The APUD system and its apudomas. Int Adv Surg Oncol, 1981, 4: 255–76.
39. Toumpanakis, C.G., Caplin, M.E.: Molecular genetics of gastroenteropancreatic neuroendocrine tumors. Am J Gastroenterol, 2008, 103/3: 729–32.
40. Tsukada, T., Nagamura, Y., Ohkura, N.: MEN1 gene and its mutations: basic and clinical implications. Cancer Sci, 2008, 100/2: 209–15.
41. Tucker, O.N., Crotty, P.L., Conlon, K.C.: The management of insulinoma. Br J Surg, 2006, 93/3: 264–75.
42. Warner, R.R: Enteroendocrine tumors other than carcinoid: a review of clinically significant advances. Gastroenterology, 2005, 128/6: 1668–84.
Štítky
Patológia Súdne lekárstvo ToxikológiaČlánok vyšiel v časopise
Česko-slovenská patologie
2009 Číslo 3
Najčítanejšie v tomto čísle
- Neuroendokrinní nádory trávicího ústrojí – historie a současnost
- Folliculitis perforans Kazuistický prípad a diferenciálna diagnostika choroby
- Doc. MUDr. Viera Povýšilová, CSc. – ohlédnutí za životní dráhou
- Systémové amyloidózy v biopsiích ledvin